Mereo BioPharma Group plc MREO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uplift Ally Financial Q1 2026 Earnings EPS Surpasses Estimates by 165 Despite Small Stock Decline SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience AMPH Q1 2026 Earnings EPS Misses Estimates by 416 Amid Operational Headwinds Cogent Biosciences Inc Q1 2026 Earnings Wider Loss but Stock Edges Higher ITRG Q1 2026 Earnings EPS Falls Short of Estimates as Development Costs Rise PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory ETR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Challenges FANG Q1 2026 Earnings EPS Beats by 255 as Strong Operations Deliver Yet Shares Slip DSGN Q1 2026 Earnings Narrowed Loss Per Share Misses on Improved Operating Efficiency EME Q1 2026 Earnings EPS Surges 1487 Above Estimates Stock Gains FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower